Monetizing Science: Turning an Asset into Value through IPOs
PharmaTalkRadio16 Okt 2019

Monetizing Science: Turning an Asset into Value through IPOs

This panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision making on prioritization within portfolios. Panelists include: David Epstein, Flagship PioneeringDan Passeri, Cue Biopharma Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
allt-du-velat-veta
ufo-sverige
svd-nyhetsartiklar
rss-vetenskapsradion
hacka-livet
barnpsykologerna
halsorevolutionen
medicinvetarna
bildningspodden
rss-vetenskapsradion-2
det-morka-psyket
rss-spraket
sexet
ufo-sverige-2
vetenskapsradion
rss-kriminologerna
rss-geopodden-2
paranormalt-med-caroline-giertz